The Fever and Antipyretic in Critically Illness Evaluation Study
Launched by JAPANESE SOCIETY OF INTENSIVE CARE MEDICINE · Jul 15, 2009
Trial Information
Current as of May 30, 2025
Completed
Keywords
ClinConnect Summary
Fever is common in critically ill patients.Antipyretic therapy for fever is routinely performed in intensive care.There are studies to assess the relationship between fever and mortality in non-neurological ICU. However, all of them did not have any information of antipyretic therapy. There are two small, single center RCT, which suggested a potential risk for antipyretic therapy. Thus, a large RCT might be ethically difficult.
It is unfortunate that there is not enough information on how the investigators should control body temperature in non-neurological critically ill patients, because...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult non-neurological critically ill patients (20 years old or older).
- • ICU patients expected to require intensive care for more than 48 hour.
- Exclusion Criteria:
- • Patients with brain injury (suspected or proven)
About Japanese Society Of Intensive Care Medicine
The Japanese Society of Intensive Care Medicine (JSICM) is a leading professional organization dedicated to advancing the field of intensive care medicine in Japan. With a mission to promote high standards of care, education, and research, JSICM supports clinical trials that aim to improve patient outcomes and enhance the efficacy of critical care practices. The society fosters collaboration among healthcare professionals, researchers, and institutions, facilitating the dissemination of knowledge and innovative approaches in intensive care. Through its commitment to evidence-based medicine and multidisciplinary cooperation, JSICM plays a pivotal role in shaping the future of critical care in Japan and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bunkyo Ku, Tokyo, Japan
Songpa Gu, Seoul, Korea, Republic Of
Patients applied
Trial Officials
Younsuck Koh, M.D. PhD
Study Chair
Korean Society of Critical Care Medicine
Masaji Nishimura, M.D. PhD
Study Chair
Japanese Society of Intensive Care Medicine
Jae Yeol Kim, M.D.
Principal Investigator
Korean Society of Critical Care Medicine
Gee Young Suh, M.D.
Principal Investigator
Korean Society of Critical Care Medicine
Moritoki Egi, M.D.
Principal Investigator
Japanese Society of Intensive Care Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials